SUMMARY
LITHIUM CARBONATE Extended Release Tablets USP, 450 mg
Lithium Carbonate Extended Release Tablets USP contain lithium carbonate, a white, light alkaline powder with molecular formula Li2CO3 and molecular weight 73.
Lithium Carbonate Extended Release Tablets USP are indicated in the treatment of manic episodes of manic-depressive illness. Maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania.
Typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. When given to a patient experiencing a manic episode, Lithium Carbonate Extended Release Tablets USP may produce a normalization of symptomatology within 1 to 3 weeks.
|
NEWS HIGHLIGHTS RELATED TO LITHIUM CARBONATE
Media Articles Related to Lithium Carbonate (Lithium)
Looking Forward, Looking Back, The Journey Of General Practice, 11-12 October, Hobart, Tasmania
Source: Conferences News From Medical News Today [2008.10.08]
Seroquel XL (Quetiapine Prolonged Release): A Once Daily Formulation For Bipolar Mania And Schizophrenia Launches Today, UK
Source: Bipolar News From Medical News Today [2008.09.15]
Bipolar Disorder (Mania)
Source: MedicineNet aripiprazole Specialty [2007.10.01]
Childhood Bipolar Disorder Could Extend Into Young Adulthood
Source: Bipolar News From Medical News Today [2008.10.07]
Forest Laboratories, Inc. And Gedeon Richter Plc Announce Positive Phase II Results With The Investigational Antipsychotic Cariprazine
Source: Bipolar News From Medical News Today [2008.10.01]
Published Studies Related to Lithium Carbonate (Lithium)
Serotonin transporter gene and response to lithium augmentation in depression. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? [2008.03]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. [2007.10]
Clinical Trials Related to Lithium Carbonate (Lithium)
Long-Term Lithium Treatment for Aggressive Conduct Disorder [Completed]
Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury [Active, not recruiting]
A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania [Active, not recruiting]
Safety and Efficacy Study of Lithium in Bipolar Disorder [Active, not recruiting]
Pharmacotherapy of Treatment-Resistant Mania [Completed]
|
